Algorae Receives A$451,359 R&D Cash Rebate from ATO
Filed with ASX · · 1 page · English
Algorae Pharmaceuticals Limited on 6ix
Earlier from Algorae Pharmaceuticals
- Half Yearly Report Announcement and Appendix 4D
- Significant Cardioprotection Qualities in AI-168 Studies
- 24 New AI-Generated Drug Targets
- AlgoraeOS Artificial Intelligence Platform Launched
- Positive results from AI-116 in vitro studies
Later from Algorae Pharmaceuticals
- Peter Mac Partners with Algorae on AI Drug Targets
- Algorae Receives A$318,771 R&D Cash Rebate from ATO
- Annual Report and Appendix 4E
- Algorae Signs Exclusive License Agreement with Sakar
- Algorae Signs Binding Term Sheet with Cadila Pharmaceuticals
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals